Clinical Study
Are Branded and Generic Extended-Release Ropinirole Formulations Equally Efficacious? A Rater-Blinded, Switch-Over, Multicenter Study
Table 2
Side-effect profile.
| | Requip (present/absent) | Ralnea (present/absent) | McNemar test ( value) |
| Orthostatic hypotension | 9/12 | 9/12 | 1.000 | Daytime sleepiness | 18/3 | 19/2 | 1.000 | Dizziness | 8/13 | 8/13 | 1.000 | Confusion | 0/21 | 2/19 | 0.500 | Dyskinesia | 14/7 | 17/4 | 0.219 | Hallucinations or pseudohallucinations | 4/17 | 3/18 | 1.000 | Sexual disturbances | 1/20 | 2/19 | 1.000 | Abdominal pain/discomfort | 2/19 | 7/14 | 0.125 | Nausea | 1/20 | 3/18 | 0.500 | Constipation | 7/14 | 6/15 | 1.000 | Oedema | 13/8 | 10/11 | 0.250 | Impulse control disorder | 0/21 | 0/21 | 1.000 |
|
|